jRCT2080222905未知3 期
Phase 2/3 clinical study of HP-3150 in patients with cancer pain.
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Multicenter, placebo-controlled, double-blind, randomized
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •Patients confirmed to have various types of cancer who were informed about their disease.
排除标准
- •Patients with abnormalities at the planned application site.
- •Patients with a serious hematologic disorder, hepatic dysfunction, renal dysfunction, hypertension, or heart failure.
- •Patients who have undergone an operation or nerve block, etc. that may affect assessment of pain.
研究者
相似试验
未知
2 期
Phase 2/3 clinical study of HP-3150 in patients with cancer pain.Cancer painJPRN-jRCT2080222905Hisamitsu Pharmaceutical Co., Inc
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.jRCT2080222960Hisamitsu Pharmaceutical Co., Inc
已完成
3 期
Phase III Study of HP-3150 in Patients with Humeroscapular Periarthritis, Cervico-omo-brachial Syndrome and TenosynovitisjRCT2080225041Hisamitsu Pharmaceutical Co., Inc.195
已完成
3 期
Phase III Study of HP-3150 in Patients with Low Back PainjRCT2080225040Hisamitsu Pharmaceutical Co., Inc.686